Tenet Healthcare (NYSE: THC) has recently received a number of price target changes and ratings updates:
- 8/3/2026 – Tenet Healthcare had its price target raised by Wells Fargo & Company from $231.00 to $281.00. They now have an “overweight” rating on the stock.
- 8/3/2026 – Tenet Healthcare was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 7/28/2026 – Tenet Healthcare had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $305.00 price target on the stock.
- 7/28/2026 – Tenet Healthcare had its price target raised by Truist Financial Corporation from $270.00 to $290.00. They now have a “buy” rating on the stock.
- 7/28/2026 – Tenet Healthcare had its price target raised by Guggenheim from $242.00 to $283.00. They now have a “buy” rating on the stock.
- 7/28/2026 – Tenet Healthcare had its price target raised by Robert W. Baird from $210.00 to $280.00. They now have a “neutral” rating on the stock.
- 7/27/2026 – Tenet Healthcare had its “overweight” rating reaffirmed by Stephens. They now have a $285.00 price target on the stock.
- 7/27/2026 – Tenet Healthcare had its price target raised by UBS Group AG from $288.00 to $308.00. They now have a “buy” rating on the stock.
- 7/27/2026 – Tenet Healthcare was given a new $308.00 price target by Piper Sandler.
- 7/27/2026 – Tenet Healthcare had its price target raised by Morgan Stanley from $254.00 to $274.00. They now have an “overweight” rating on the stock.
- 7/27/2026 – Tenet Healthcare was given a new $270.00 price target by Raymond James Financial, Inc..
- 7/27/2026 – Tenet Healthcare had its “overweight” rating reaffirmed by Cantor Fitzgerald.
- 7/27/2026 – Tenet Healthcare had its price target raised by TD Cowen from $233.00 to $263.00. They now have a “buy” rating on the stock.
- 7/27/2026 – Tenet Healthcare had its price target raised by Royal Bank Of Canada from $236.00 to $283.00. They now have an “outperform” rating on the stock.
- 7/26/2026 – Tenet Healthcare was upgraded by Wall Street Zen from “hold” to “buy”.
- 7/24/2026 – Tenet Healthcare had its price target raised by UBS Group AG from $288.00 to $308.00. They now have a “buy” rating on the stock.
- 7/24/2026 – Tenet Healthcare had its price target raised by Barclays PLC from $240.00 to $271.00. They now have an “overweight” rating on the stock.
- 7/20/2026 – Tenet Healthcare had its price target lowered by Guggenheim from $252.00 to $242.00. They now have a “buy” rating on the stock.
- 7/18/2026 – Tenet Healthcare was downgraded by Wall Street Zen from “buy” to “hold”.
- 7/13/2026 – Tenet Healthcare had its price target raised by Wells Fargo & Company from $213.00 to $231.00. They now have an “overweight” rating on the stock.
- 7/8/2026 – Tenet Healthcare had its price target raised by Barclays PLC from $238.00 to $240.00. They now have an “overweight” rating on the stock.
- 6/22/2026 – Tenet Healthcare had its price target lowered by TD Cowen from $242.00 to $233.00. They now have a “buy” rating on the stock.
Insider Transactions at Tenet Healthcare
In related news, Director Christopher S. Lynch sold 3,837 shares of the firm’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $243.44, for a total value of $934,079.28. Following the completion of the sale, the director directly owned 9,568 shares in the company, valued at $2,329,233.92. This trade represents a 28.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nadja West sold 3,000 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 33,353 shares of company stock worth $7,683,517. 0.97% of the stock is currently owned by corporate insiders.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- Tether Strikes Gold: Crypto’s Physical Pivot
- Jersey Mike’s Serves Fresh Gains After IPO Stumble
- 3 Drone Stocks That Should Soar After the Summer Slump
- Tyson Foods Offers a Meaty Opportunity for Income Investors
Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
-JSOL.png){kind=small}